FREE SHIPPING ON ORDERS OVER $150

glutathione myscobacterium smegmatis Application of Mycobacterium as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Frontiers | Mycobacterium smegmatis Bacteria

$23.66

Quantity
- +
Description

Using a similar experimental design, we employed RNA-Seq to profile the transcriptome response to each of the two molecules

glutathione myscobacterium smegmatis Application of Mycobacterium as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Frontiers | Mycobacterium smegmatis Bacteria

5HSI and 5HSJ

glutathione myscobacterium smegmatis Application of Mycobacterium as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Frontiers | Mycobacterium smegmatis Bacteria

In A-induced AD model mice and APP23/PS45 double transgenic AD model mice, UA treatment promotes A clearance and improves cognitive deficits by restoring TFEB-dependent autophagy [217](Fig

glutathione myscobacterium smegmatis Application of Mycobacterium as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Frontiers | Mycobacterium smegmatis Bacteria

In addition, cationic nanoparticles (CNP-siCCR2) encapsulated with siCCR2 can effectively inhibit the expression of CCR2 in monocytes and blocking the recruitment of monocytes to tumor tissues thereby changing the tumor immune microenvironment, inhibiting primary tumor growth and reducing tumor metastasis, and improving the anti-tumor effect of chemotherapy drugs (29)

glutathione myscobacterium smegmatis Application of Mycobacterium as a surrogate to evaluate drug leads against Mycobacterium tuberculosis Frontiers | Mycobacterium smegmatis Bacteria

You may also like

Frontiers

US$ 20.21

4.9 (10 reviews)

recommand products